Daptomycin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Complicated Skin Structure Infections, Bacteremia, Others); Age-Group (Pediatric, Adult); Strenth (350mg, 500mg)

Report Code: TIPRE00021684 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Daptomycin, an antibiotic, is used to heal bacterial infections occurring on the skin and underlying tissues and conditions that have entered the bloodstream. Daptomycin is used for complicated infections, including methicillin-resistant Staphylococcus aureus (MRSA) or superbug infections.

MARKET DYNAMICS

Increasing difficult skin and skin structure infections, rising infections in the proper bloodstream, and rising right-sided infective endocarditis are the major factors for market growth. For instance, according to the World Health Organization (WHO) report, in 2018, skin diseases affected almost 900 million people in the world. Out of which, many were associated with changes in the skin, from skin itching to changes in color, feel, and appearance.

MARKET SCOPE

The "Daptomycin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Daptomycin market with detailed market segmentation by indication, age-group, strength. The daptomycin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Daptomycin market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The daptomycin market is segmented on the basis of indication, age-group, and strength. Based on indication, the market is segmented as complicated skin structure infections, bacteremia, and others. Based on age-group, the market is segmented as pediatric and adult. Based on strength, market is segmented as 350mg and 500mg.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Daptomycin market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Daptomycin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Daptomycin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Daptomycin market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Daptomycin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Daptomycin market are anticipated to have lucrative growth opportunities in the future with the rising demand for Daptomycin in the global market. Below mentioned is the list of few companies engaged in the daptomycin market.

The report also includes the profiles of key players in Daptomycin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and indication, age-group, strength offered, financial information of last 3 years, key development in past five years.

  •   MERCK AND CO.
  •   PFIZER
  •   TEVA PHARMACEUTICALS
  •   MYLAN
  •   FRESENIUS KABI
  •   SAGENT PHARMACEUTICALS
  •   XELLIA
  •   HISUN
  •   HENGRUI PHARMA
  •   HUADONG MEDICINE

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Daptomycin Market - By Indication
1.3.2 Daptomycin Market - By Age-Group
1.3.3 Daptomycin Market - By Strenth
1.3.4 Daptomycin Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DAPTOMYCIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DAPTOMYCIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DAPTOMYCIN MARKET - GLOBAL MARKET ANALYSIS
6.1. DAPTOMYCIN - GLOBAL MARKET OVERVIEW
6.2. DAPTOMYCIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DAPTOMYCIN MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. COMPLICATED SKIN STRUCTURE INFECTIONS
7.3.1. Overview
7.3.2. Complicated Skin Structure Infections Market Forecast and Analysis
7.4. BACTEREMIA
7.4.1. Overview
7.4.2. Bacteremia Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. DAPTOMYCIN MARKET - REVENUE AND FORECASTS TO 2028 - AGE-GROUP
8.1. OVERVIEW
8.2. AGE-GROUP MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADULT
8.4.1. Overview
8.4.2. Adult Market Forecast and Analysis
9. DAPTOMYCIN MARKET - REVENUE AND FORECASTS TO 2028 - STRENTH
9.1. OVERVIEW
9.2. STRENTH MARKET FORECASTS AND ANALYSIS
9.3. 350MG
9.3.1. Overview
9.3.2. 350mg Market Forecast and Analysis
9.4. 500MG
9.4.1. Overview
9.4.2. 500mg Market Forecast and Analysis
10. DAPTOMYCIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Daptomycin Market Overview
10.1.2 North America Daptomycin Market Forecasts and Analysis
10.1.3 North America Daptomycin Market Forecasts and Analysis - By Indication
10.1.4 North America Daptomycin Market Forecasts and Analysis - By Age-Group
10.1.5 North America Daptomycin Market Forecasts and Analysis - By Strenth
10.1.6 North America Daptomycin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Daptomycin Market
10.1.6.1.1 United States Daptomycin Market by Indication
10.1.6.1.2 United States Daptomycin Market by Age-Group
10.1.6.1.3 United States Daptomycin Market by Strenth
10.1.6.2 Canada Daptomycin Market
10.1.6.2.1 Canada Daptomycin Market by Indication
10.1.6.2.2 Canada Daptomycin Market by Age-Group
10.1.6.2.3 Canada Daptomycin Market by Strenth
10.1.6.3 Mexico Daptomycin Market
10.1.6.3.1 Mexico Daptomycin Market by Indication
10.1.6.3.2 Mexico Daptomycin Market by Age-Group
10.1.6.3.3 Mexico Daptomycin Market by Strenth
10.2. EUROPE
10.2.1 Europe Daptomycin Market Overview
10.2.2 Europe Daptomycin Market Forecasts and Analysis
10.2.3 Europe Daptomycin Market Forecasts and Analysis - By Indication
10.2.4 Europe Daptomycin Market Forecasts and Analysis - By Age-Group
10.2.5 Europe Daptomycin Market Forecasts and Analysis - By Strenth
10.2.6 Europe Daptomycin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Daptomycin Market
10.2.6.1.1 Germany Daptomycin Market by Indication
10.2.6.1.2 Germany Daptomycin Market by Age-Group
10.2.6.1.3 Germany Daptomycin Market by Strenth
10.2.6.2 France Daptomycin Market
10.2.6.2.1 France Daptomycin Market by Indication
10.2.6.2.2 France Daptomycin Market by Age-Group
10.2.6.2.3 France Daptomycin Market by Strenth
10.2.6.3 Italy Daptomycin Market
10.2.6.3.1 Italy Daptomycin Market by Indication
10.2.6.3.2 Italy Daptomycin Market by Age-Group
10.2.6.3.3 Italy Daptomycin Market by Strenth
10.2.6.4 Spain Daptomycin Market
10.2.6.4.1 Spain Daptomycin Market by Indication
10.2.6.4.2 Spain Daptomycin Market by Age-Group
10.2.6.4.3 Spain Daptomycin Market by Strenth
10.2.6.5 United Kingdom Daptomycin Market
10.2.6.5.1 United Kingdom Daptomycin Market by Indication
10.2.6.5.2 United Kingdom Daptomycin Market by Age-Group
10.2.6.5.3 United Kingdom Daptomycin Market by Strenth
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Daptomycin Market Overview
10.3.2 Asia-Pacific Daptomycin Market Forecasts and Analysis
10.3.3 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Age-Group
10.3.5 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Strenth
10.3.6 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Daptomycin Market
10.3.6.1.1 Australia Daptomycin Market by Indication
10.3.6.1.2 Australia Daptomycin Market by Age-Group
10.3.6.1.3 Australia Daptomycin Market by Strenth
10.3.6.2 China Daptomycin Market
10.3.6.2.1 China Daptomycin Market by Indication
10.3.6.2.2 China Daptomycin Market by Age-Group
10.3.6.2.3 China Daptomycin Market by Strenth
10.3.6.3 India Daptomycin Market
10.3.6.3.1 India Daptomycin Market by Indication
10.3.6.3.2 India Daptomycin Market by Age-Group
10.3.6.3.3 India Daptomycin Market by Strenth
10.3.6.4 Japan Daptomycin Market
10.3.6.4.1 Japan Daptomycin Market by Indication
10.3.6.4.2 Japan Daptomycin Market by Age-Group
10.3.6.4.3 Japan Daptomycin Market by Strenth
10.3.6.5 South Korea Daptomycin Market
10.3.6.5.1 South Korea Daptomycin Market by Indication
10.3.6.5.2 South Korea Daptomycin Market by Age-Group
10.3.6.5.3 South Korea Daptomycin Market by Strenth
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Daptomycin Market Overview
10.4.2 Middle East and Africa Daptomycin Market Forecasts and Analysis
10.4.3 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Age-Group
10.4.5 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Strenth
10.4.6 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Daptomycin Market
10.4.6.1.1 South Africa Daptomycin Market by Indication
10.4.6.1.2 South Africa Daptomycin Market by Age-Group
10.4.6.1.3 South Africa Daptomycin Market by Strenth
10.4.6.2 Saudi Arabia Daptomycin Market
10.4.6.2.1 Saudi Arabia Daptomycin Market by Indication
10.4.6.2.2 Saudi Arabia Daptomycin Market by Age-Group
10.4.6.2.3 Saudi Arabia Daptomycin Market by Strenth
10.4.6.3 U.A.E Daptomycin Market
10.4.6.3.1 U.A.E Daptomycin Market by Indication
10.4.6.3.2 U.A.E Daptomycin Market by Age-Group
10.4.6.3.3 U.A.E Daptomycin Market by Strenth
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Daptomycin Market Overview
10.5.2 South and Central America Daptomycin Market Forecasts and Analysis
10.5.3 South and Central America Daptomycin Market Forecasts and Analysis - By Indication
10.5.4 South and Central America Daptomycin Market Forecasts and Analysis - By Age-Group
10.5.5 South and Central America Daptomycin Market Forecasts and Analysis - By Strenth
10.5.6 South and Central America Daptomycin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Daptomycin Market
10.5.6.1.1 Brazil Daptomycin Market by Indication
10.5.6.1.2 Brazil Daptomycin Market by Age-Group
10.5.6.1.3 Brazil Daptomycin Market by Strenth
10.5.6.2 Argentina Daptomycin Market
10.5.6.2.1 Argentina Daptomycin Market by Indication
10.5.6.2.2 Argentina Daptomycin Market by Age-Group
10.5.6.2.3 Argentina Daptomycin Market by Strenth
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DAPTOMYCIN MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DAPTOMYCIN MARKET, KEY COMPANY PROFILES
13.1. MERCK AND CO.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. TEVA PHARMACEUTICALS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MYLAN
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. FRESENIUS KABI
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SAGENT PHARMACEUTICALS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. XELLIA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HISUN
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HENGRUI PHARMA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. HUADONG MEDICINE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. MERCK AND CO.
2. PFIZER
3. TEVA PHARMACEUTICALS
4. MYLAN
5. FRESENIUS KABI
6. SAGENT PHARMACEUTICALS
7. XELLIA
8. HISUN
9. HENGRUI PHARMA
10. HUADONG MEDICINE
11. CIPLA
12. BE PHARMACEUTICALS
13. REDDY'S LABORATORIES
14. NICHI-IKO PHARMACEUTICAL
15. NOVO HOLDINGS A/S
TIPRE00021684
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking